Koyfin Home > Directory > Health Care > Anika Therapeutics > EV / EBITDA (ltm)

Anika Therapeutics EV / EBITDA (ltm) Chart (ANIK)

Anika Therapeutics annual/quarterly EV / EBITDA (ltm) from 2010 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Anika Therapeutics EV / EBITDA (ltm) for the quarter ending October 10, 2020 was 11.98 a -5.24% decrease of -0.63 year over year
  • Anika Therapeutics EV / EBITDA (ltm) for the last 12 months ending October 10, 2020 was 11.98 a -5.24% decrease of -0.63 year over year
  • Anika Therapeutics Annual EV / EBITDA (ltm) for 2020 was 11.98 a -0.82% decrease of -0.10 from 2019
  • Anika Therapeutics Annual EV / EBITDA (ltm) for 2020 was 12.08 a -1.92% decrease of -0.23 from 2019
  • Anika Therapeutics Annual EV / EBITDA (ltm) for 2020 was 12.31 a -2.42% decrease of -0.30 from 2019
Other Valuation Metrics:
  • Anika Therapeutics Market Cap for the quarter ending June 06, 2018 was $458m a -85.66% decrease of -392m year over year
  • Anika Therapeutics Price / Book for the quarter ending June 06, 2018 was 1.79 a -94.67% decrease of -1.69 year over year
  • Anika Therapeutics Enterprise Value for the quarter ending June 06, 2018 was $295m a -139.86% decrease of -412m year over year
View Chart On Koyfin

Quarterly ANIK EV / EBITDA (ltm) Data

10/202011.98
10/202012.08
10/202012.31
10/202012.61
10/202012.56
10/202012.68
10/202013.37
10/202013.67
10/202013.59
10/202013.26

Annual ANIK EV / EBITDA (ltm) Data

202011.98
202012.08
202012.31
202012.61
202012.56
202012.68
202013.37
202013.67
202013.59
202013.26